Sign In
Buy HRMY
$32.10
+1.19 (+3.85%)
At Close: Jun 03, 2026
Wall Street Analysts See a 32.82% Upside in Harmony Biosciences (HRMY): Can the Stock Really Move This High?
10:56am, Friday, 19'th Jul 2024
The average of price targets set by Wall Street analysts indicates a potential upside of 32.8% in Harmony Biosciences (HRMY). While the effectiveness of this highly sought-after metric is questionable
Are Investors Undervaluing Harmony Biosciences (HRMY) Right Now?
10:57am, Wednesday, 17'th Jul 2024
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest
7 Cheap Biotech Stocks With Major Upside Potential
06:00am, Tuesday, 09'th Jul 2024
Intuitively, the case for biotechnology-related investments comes across rather obviously: the concept of healthcare should be a permanent one. And because of this permanence, the expected market valu
5 High Earnings Yield Value Stocks That You Shouldn't Ignore
09:31am, Monday, 08'th Jul 2024
Unlock your portfolio value by investing in stocks like HRMY, GPRK, GCT, CMRE and ARKO to fetch handsome returns.
7 Undervalued Biotech Stocks to Buy for Big-Time Returns
02:18pm, Monday, 01'st Jul 2024
Every investment category must answer the big question, why? For undervalued biotech stocks, it comes down to advantaging a supremely relevant sector without paying full price.
HARMONY BIOSCIENCES ACKNOWLEDGES U.S. FOOD & DRUG ADMINISTRATION (FDA) ACTION DENYING THE CITIZEN PETITION FOR WAKIX® (PITOLSIANT)
08:05am, Tuesday, 25'th Jun 2024
FDA confirms the favorable benefit-risk profile of WAKIX Harmony Biosciences focused on continuing to advance its pipeline assets across three rare CNS franchises; anticipates at least one new product
7 Biotech Stocks to Buy on the Dip: June 2024
12:56pm, Monday, 24'th Jun 2024
Fundamentally, the biotechnology sphere enjoys a powerful catalyst: wealth without health means nothing. Yes, it's important to save money and invest for the future.
PLYMOUTH MEETING, Pa. , June 24, 2024 /PRNewswire/ -- Harmony Biosciences (Nasdaq: HRMY) today announced that the U.S. Food and Drug Administration (FDA) has approved its supplemental New Drug Applica
PLYMOUTH MEETING, Pa. , June 5, 2024 /PRNewswire/ -- Harmony Biosciences (Nasdaq: HRMY) presented data from its Phase 2 signal detection study showing that pitolisant reduced excessive daytime sleepin
HARMONY BIOSCIENCES TO PARTICIPATE IN GOLDMAN SACHS 45th ANNUAL GLOBAL HEALTHCARE CONFERENCE
08:05am, Tuesday, 28'th May 2024
PLYMOUTH MEETING, Pa. , May 28, 2024 /PRNewswire/ -- Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY), today announced that Harmony's management team will participate in a fireside chat at the upcomi
Amalgamated Bank Lowers Position in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY)
05:01am, Monday, 20'th May 2024
Amalgamated Bank lessened its position in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY – Free Report) by 8.1% in the fourth quarter, according to the company in its most recent filing with th
Looking for a Growth Stock? 3 Reasons Why Harmony Biosciences (HRMY) is a Solid Choice
01:46pm, Wednesday, 01'st May 2024
Harmony Biosciences (HRMY) could produce exceptional returns because of its solid growth attributes.
HRMY or TECH: Which Is the Better Value Stock Right Now?
12:41pm, Wednesday, 01'st May 2024
Investors interested in Medical - Biomedical and Genetics stocks are likely familiar with Harmony Biosciences Holdings, Inc. (HRMY) and Techne (TECH). But which of these two stocks offers value invest
Harmony Biosciences Holdings, Inc (HRMY) Q1 2024 Earnings Call Transcript
01:49pm, Tuesday, 30'th Apr 2024
Harmony Biosciences Holdings, Inc (NASDAQ:HRMY ) Q1 2024 Earnings Conference Call April 30, 2024 8:30 AM ET Company Participants Luis Sanay - Head of Investor Relations Jeffrey Dayno - President & Chi
WAKIX® (pitolisant) Net Revenue of $154.6 Million for First Quarter 2024; ~30% Growth Year-over-Year Supplemental New Drug Application for Pitolisant in Idiopathic Hypersomnia Planned for Second Half
